Imunon, Inc. (IMNN) stock
Close on Nov 16, 2026Market cap $3.33MP/E –Yield –
Earnings
Imunon's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Imunon's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 30, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026before the open | – | – | -$0.64 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026before the open | – | – | -$0.84 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 31, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 13, 2025before the open | – | – | -$1.16 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025before the open | – | – | -$2.15 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 12, 2025before the open | – | – | -$0.28 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 27, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | – | – | -$0.34 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 14, 2024before the open | – | – | -$0.51 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 13, 2024before the open | – | – | -$0.52 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023before the open | – | – | -$0.37 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 10, 2023before the open | – | – | -$0.61 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 30, 2023before the open | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022before the open | $125.00K | 0.0% | -$0.87 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 15, 2022before the open | $125.00K | – | -$0.87 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 16, 2022before the open | $125.00K | – | -$1.82 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 31, 2022before the open | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 15, 2021before the open | $125.00K | – | -$0.06 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 12, 2021before the open | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 14, 2021before the open | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 19, 2021before the open | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 16, 2020before the open | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 14, 2020before the open | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 15, 2020before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Imunon guided for has been reported
Guidance history
Every forecast Imunon put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 14, 2022 | projected cash utilization | FY2022 | $5.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Imunon filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Update
- Results
- Update
- Results
- Results
- Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ RulesNews
- Results
- Results
- News
- Update
- News
- Results
- News
See a number that looks wrong?